Literature DB >> 17367871

Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS).

V Lehmensiek1, S D Süssmuth, J Brettschneider, G Tauscher, S Felk, F Gillardon, H Tumani.   

Abstract

We used two-dimensional difference in-gel electrophoresis (2-D-DIGE) for proteome analysis of cerebrospinal fluid (CSF) in Guillain-Barré syndrome (GBS). Spots showing >2-fold difference between GBS and controls were analysed using MALDI-TOF mass spectrometry. Proteins that were up-regulated in GBS included haptoglobin, serine/threonine kinase 10, alpha-1-antitrypsin, SNC73, alpha II spectrin, IgG kappa chain and cathepsin D preprotein, while transferrin, caldesmon, GALT, human heat shock protein 70, amyloidosis patient HL-heart-peptide 127aa and transthyretin were down-regulated. Some of these proteins are reported in CSF of GBS for the first time. Accordingly, the 2-D-DIGE technology may be useful to identify disease-specific proteins in patients with GBS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17367871     DOI: 10.1016/j.jneuroim.2007.01.022

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS).

Authors:  Johannes Brettschneider; Helga Mogel; Vera Lehmensiek; Tino Ahlert; Sigurd Süssmuth; Albert C Ludolph; Hayrettin Tumani
Journal:  Neurochem Res       Date:  2008-05-15       Impact factor: 3.996

2.  Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome.

Authors:  Yin-Rong Yang; Shi-Lian Liu; Zhao-Yu Qin; Fu-Jun Liu; Yan-Jiang Qin; Shu-Mei Bai; Zhe-Yu Chen
Journal:  Cell Mol Neurobiol       Date:  2008-03-15       Impact factor: 5.046

Review 3.  Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?

Authors:  Johannes Brettschneider; Axel Petzold; Sigurd Süssmuth; Hayrettin Tumani
Journal:  J Neurol       Date:  2009-02-16       Impact factor: 4.849

4.  The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.

Authors:  Rustam H Ziganshin; Olga M Ivanova; Yakov A Lomakin; Alexey A Belogurov; Sergey I Kovalchuk; Igor V Azarkin; Georgij P Arapidi; Nikolay A Anikanov; Victoria O Shender; Mikhail A Piradov; Natalia A Suponeva; Anna A Vorobyeva; Alexander G Gabibov; Vadim T Ivanov; Vadim M Govorun
Journal:  Mol Cell Proteomics       Date:  2016-05-03       Impact factor: 5.911

5.  Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis.

Authors:  Daniel Martins-de-Souza; Wagner F Gattaz; Andrea Schmitt; Christiane Rewerts; Sérgio Marangoni; José C Novello; Giuseppina Maccarrone; Christoph W Turck; Emmanuel Dias-Neto
Journal:  J Neural Transm (Vienna)       Date:  2008-11-26       Impact factor: 3.575

6.  Noninvasive assessments of optic nerve neurodegeneration in transgenic mice with isolated optic neuritis.

Authors:  Venu Talla; Cui Yang; Gerry Shaw; Vittorio Porciatti; Rajeshwari D Koilkonda; John Guy
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-01       Impact factor: 4.799

7.  Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia.

Authors:  Daniel Martins-de-Souza; Wagner F Gattaz; Andrea Schmitt; Christiane Rewerts; Giuseppina Maccarrone; Emmanuel Dias-Neto; Christoph W Turck
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-01-22       Impact factor: 5.270

8.  Could proteomic research deliver the next generation of treatments for pneumococcal meningitis?

Authors:  U R Goonetilleke; S A Ward; S B Gordon
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-05-27

Review 9.  Could Proteomics Become a Future Useful Tool to Shed Light on the Mechanisms of Rare Neurodegenerative Disorders?

Authors:  Maddalena Cagnone; Anna Bardoni; Paolo Iadarola; Simona Viglio
Journal:  High Throughput       Date:  2018-01-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.